top of page

Cardiovascular

Health

CardioMetabolic 

Health

Lung Health

Bone Health

All-in-one AI-CVD

497e6f54-782b-4e077a-3a7144e4f3e4.png

AutoFracture

(coming soon)

upscaled_5x.png
upscaled_5x.png
upscaled_5x.png
upscaled_5x.png
upscaled_5x.png
upscaled_5x.png
upscaled_5x.png
upscaled_5x.png
upscaled_5x.png
0bdba309-a76a-4215-b207-90a7932bb681.png
iScreen Shoter - 20260520111737117 1.png
Frame 1000004271.png
iScreen Shoter - 20260520105243724 1.png
iScreen Shoter - 20260520105243724 1.png
iScreen Shoter - 20260520100645073 1.png

1 Non-Contrast Scan              10+ Actionable Reports

AI-Derived Left Atrial Volume Index,LA/RA and LA/LV Volume Ratios FromCoronary Artery Calcium (CAC) Scans PredictLong-Term Atrial Fibrillation and Stroke

  • 3 days ago
  • 1 min read

ESC Congress 2026 - 28 - 31 Aug 2026

Munich, Germany

Organised by: European Society of Cardiology (ESC) visual



Can a routine coronary calcium scan reveal more about a patient’s long-term cardiovascular risk?

A new HeartLung.AI study explores how AI-derived cardiac chamber measurements from routine coronary artery calcium (CAC) scans may help predict future atrial fibrillation and stroke.

Using data from the MESA and Framingham Heart Study cohorts, researchers evaluated AI-derived measures including:

  • Left Atrial Volume Index (LAVI)

  • LA/RA Volume Ratio

  • LA/LV Volume Ratio

The study examined their association with long-term atrial fibrillation and stroke outcomes, with follow-up extending up to 17 years.

The findings demonstrate the potential of AI to extract clinically meaningful cardiovascular information from CT scans originally acquired for coronary calcium assessment—expanding the value of an existing scan beyond its original purpose.

One scan. More insight. Greater opportunity for earlier risk assessment.

Download the full presentation below to explore the methodology, results, and clinical implications.



Comments


Ready to Unlock the Value in Your CT Scans?

Join leading healthcare providers using AI-CVD to save lives and increase revenue, and lead the future of preventive cardiology.

  • Twitter
  • LinkedIn
  • Facebook
  • Instagram
  • Youtube

2450 Holcombe Blvd
TMC Innovations
Houston, TX 77021

aicvd patent_edited_edited.jpg
ISO LOGO_edited.png

©2026 HeartLung Corporation. All Rights Reserved. US Patent Nos US9119590*, US10695022, US11610686, US18167691, US20240115224, and Patents Pending. AI-CVD, AI-CAC, AutoBMD, AutoCAC, AutoChamber and other trademarks shown on this website are protected under intellectual property rights of HeartLung Corporation in the United States.

bottom of page